Consecutive daily administration of intratracheal surfactant and human umbilical cord-derived mesenchymal stem cells attenuates hyperoxia-induced lung injury in neonatal rats

BACKGROUND: Surfactant therapy is a standard of care for preterm infants with respiratory distress and reduces the incidence of death and bronchopulmonary dysplasia in these patients. Our previous study found that mesenchymal stem cells (MSCs) attenuated hyperoxia-induced lung injury and the combina...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Stem Cell Res Ther
Autors principals: Chou, Hsiu-Chu, Chang, Chien-Hsiang, Chen, Chien-Han, Lin, Willie, Chen, Chung-Ming
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2021
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8088571/
https://ncbi.nlm.nih.gov/pubmed/33933128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-021-02335-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars